AuroMedics recalls antibiotics due to ‘particulate matter’ in product
AuroMedics Pharma LLC is voluntarily recalling two lots of injectable antibiotics following customer complaints of “red particulate matter” in the product.
Archives for May 7, 2018
Haselmeier, Common Sensing developing smart monitoring solutions for injectables
A new partnership between Haselmeier and Common Sensing aims to develop smart connected monitoring and support solutions for users of injectable medicines.
WuXi STA’s API site receives FDA nod following first inspection
WuXi STA has passed its first FDA inspection at its active pharmaceutical ingredient (API) development and manufacturing facility located in Changzhou, China.
Chinese gov't outlines changes to import tariff, clinical trial applications, IP protection
Significant regulatory changes by the Chinese government will accelerate drug development timelines and positively affect sponsors’ bottom line, says CRO.
UK commits to post-Brexit clinical trial rule harmonization but uncertainties remain
The UK government has provided the “strongest possible reassurance” that it will implement the incoming European Union Clinical Trial Regulation, whatever happens in the Brexit negotiations.
UCB to sponsor trials at ‘giant site without borders’
Neurology and immunology trial participants will undertake "site-less" clinical trials under a partnership between Science 37 and drugmaker UCB.